BIO 2014: Proper valuation of IP important in all sectors, says Rader

Learning to determine the value technological advance has contributed requires a great degree of sophistication, Randall Rader said in a session on protecting biotechnology innovations in the US and Latin America at the 2014 BIO International Convention in San Diego, California, yesterday (Tuesday).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Moderna VP and regulatory expert moves to private practice

2 February 2026 The third European life sciences hire in recent months brings in-house regulatory expertise from Moderna in Munich.

Careers

Crowell adds tech partner with in-house and private practice expertise

2 February 2026 The seasoned IP leader has left biotech GRAIL to expand the firm’s capabilities in life sciences, technology, and AI in California.

Careers

Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger

30 January 2026 Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences and transatlantic services.

More features

Moderna VP and regulatory expert moves to private practice

Crowell adds tech partner with in-house and private practice expertise

Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger

Pearce IP grows practice with senior patent hire

Sanofi suffers setback in insulin monopoly dispute

Firm adds seven-lawyer team in second major merger

Eli Lilly’s Mounjaro tops list of cyber squatter targets

The quantum advantage: IP considerations for the next generation of life sciences innovation

BIO 2014: Proper valuation of IP important in all sectors, says Rader

More on this story

Editor's picks

Editor's picks

More features